Transcranial Magnetic Stimulation for the Treatment of Major Depression: Clinical, Economic, and Practical Issues Part II

Abstract

clinical and economic burden of major depression; the compounding issue of treatment resistance; and cost analyses comparing transcranial magnetic stimulation (TMS) with standard clinical care (e.g., complex pharmacotherapy, electrconvulsive therapy [ECT]) for treatmentresistant depression (TRD). Part II reviews practical issues in the clinical use of TMS, which have emerged since its approval by the FDA for this indication.